Skip to main content

Albert Gil Vila

Institutions of which they are part

Predoctoral researcher
Systemic Diseases
Vall Hebron Institut de Recerca

Albert Gil Vila

Institutions of which they are part

Predoctoral researcher
Systemic Diseases
Vall Hebron Institut de Recerca

Projects

Caracterización de las células patogénicas del músculo y piel de pacientes con Dermatomiositis y Síndrome Antisintetasa y estudio de aplicabilidad traslacional.

IP: Ernesto Trallero Araguas
Collaborators: Albert Selva O'Callaghan, Raul Tortosa Mendez, Albert Gil Vila, Gloria Aparicio Español, Caracterización de las células patogénicas del músculo y piel de pacientes con Dermatomiositis y Síndrome Antisintetasa y estudi, Hugo Fernando Avalos Bogado
Funding agency: Instituto de Salud Carlos III
Funding: 135520
Reference: PI22/00708
Duration: 01/01/2023 - 31/12/2025

Related news

A Vall d’Hebron team demonstrates, for the first time, the potential of optical genome mapping to detect genetic alterations associated with this rare disease that are not identified using conventional methods.

The study describes the first documented case worldwide of hereditary angioedema transmission through assisted reproduction.

15 researchers from the Rheumatology, Systemic Diseases and the Physiology and Pathophysiology of the Digestive Tract groups gave around 25 presentations.

Related professionals

Ramon Gonzalez Rioja

Ramon Gonzalez Rioja

Predoctoral researcher
Pharmacokinetic Nanoparticles
Read more
Miriam Correa Losada

Miriam Correa Losada

Research technician
Stroke research
Read more
Jesús David González Riveros

Jesús David González Riveros

Research technician
Stroke research
Read more
Beatriz Alvarez Vallejo

Beatriz Alvarez Vallejo

Senior researcher
Infection and immunity in pediatric patients
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.